Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    18669874 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide;   Drug: Zometa

Study has passed its completion date and status has not been verified in more than two years.